Access to funding
Since 2012, businesses based at SBC have attracted over £3bn in equity investment, IPO/FPO, grants and acquisitions and received £181m in grant funding. Of the total, over 72% has been in companies with a focus on cell and gene technologies.
Attraction of national and international funders
SBC has relationships with many investors, and the rapid growth of companies at SBC has drawn numerous national and international funders to invest in occupiers.
Mentoring
Campus CEO and operations groups
An opportunity for peer-to-peer mentoring groups for CEOs or office managers to meet in an informal setting to share experiences and advice.
SBC consultants’ group
Occupier companies can connect with experts who offer insights, support and guidance, acting as a ‘critical friend’ along the various stages of the therapeutics development pipeline.
Mentoring
Campus CEO and operations groups
An opportunity for peer-to-peer mentoring groups for CEOs or office managers to meet in an informal setting to share experiences and advice.
SBC consultants’ group
Occupier companies can connect with experts who offer insights, support and guidance, acting as a ‘critical friend’ along the various stages of the therapeutics development pipeline.
Networking
Campus CEO and operations groups
An opportunity for peer-to-peer mentoring groups for CEOs or office managers to meet in an informal setting to share experiences and advice.
SBC consultants’ group
Occupier companies can connect with experts who offer insights, support and guidance, acting as a ‘critical friend’ along the various stages of the therapeutics development pipeline.
Networking
Campus CEO and operations groups
An opportunity for peer-to-peer mentoring groups for CEOs or office managers to meet in an informal setting to share experiences and advice.
SBC consultants’ group
Occupier companies can connect with experts who offer insights, support and guidance, acting as a ‘critical friend’ along the various stages of the therapeutics development pipeline.
